Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fallopian Tube Neoplasms × demcizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Neoplasm Metastasis 5 Pancreatic Neoplasms 2 Lung Neoplasms 1 Lung Diseases 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Carboplatin 144 Paclitaxel 132 Bevacizumab 73 Gemcitabine 41 Taxes 39 liposomal doxorubicin 36 pembrolizumab 32 Topotecan 32 Cisplatin 32 Cyclophosphamide 23 olaparib 22 Immunoglobulin G 21 Disulfides 21 Docetaxel 19 Specimen Handling 18 Drug Therapy 17 niraparib 15 Magnetic Resonance Spectroscopy 15 Biopsy 15 mirvetuximab soravtansine 14 Doxorubicin 13 Nivolumab 11 Hyperthermic Intraperitoneal Chemotherapy 11 rucaparib 10 Albumin-Bound Paclitaxel 10 Platinum 9 Cytoreduction Surgical Procedures 9 Chemotherapy, Adjuvant 9 130-nm albumin-bound paclitaxel 9 veliparib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01952249 2020-09-09

SIERRA

Mereo BioPharma

Phase 1 Terminated

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡